BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23701286)

  • 41. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β-hydroxysteroid dehydrogenase-1 (HSD1) inhibitor in humans: liver and adipose tissue 11β-HSD1 inhibition after acute and multiple administrations over 2 weeks.
    Freude S; Heise T; Woerle HJ; Jungnik A; Rauch T; Hamilton B; Schölch C; Huang F; Graefe-Mody U
    Diabetes Obes Metab; 2016 May; 18(5):483-90. PubMed ID: 26799632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
    Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
    Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study.
    Bini J; Bhatt S; Hillmer AT; Gallezot JD; Nabulsi N; Pracitto R; Labaree D; Kapinos M; Ropchan J; Matuskey D; Sherwin RS; Jastreboff AM; Carson RE; Cosgrove K; Huang Y
    Mol Imaging Biol; 2020 Aug; 22(4):1124-1131. PubMed ID: 32133575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates.
    Morita J; Hakuno F; Hizuka N; Takahashi S; Takano K
    Endocr J; 2009; 56(4):561-70. PubMed ID: 19352050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N; Kubota S; Kato I; Kobayashi Y
    J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.
    Nyirenda MJ; Carter R; Tang JI; de Vries A; Schlumbohm C; Hillier SG; Streit F; Oellerich M; Armstrong VW; Fuchs E; Seckl JR
    Diabetes; 2009 Dec; 58(12):2873-9. PubMed ID: 19720800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome.
    Mariniello B; Ronconi V; Rilli S; Bernante P; Boscaro M; Mantero F; Giacchetti G
    Eur J Endocrinol; 2006 Sep; 155(3):435-41. PubMed ID: 16914598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes.
    Peng K; Pan Y; Li J; Khan Z; Fan M; Yin H; Tong C; Zhao Y; Liang G; Zheng C
    Sci Rep; 2016 Nov; 6():37160. PubMed ID: 27841334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
    Valsamakis G; Anwar A; Tomlinson JW; Shackleton CH; McTernan PG; Chetty R; Wood PJ; Banerjee AK; Holder G; Barnett AH; Stewart PM; Kumar S
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
    Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
    Wang J; Sun B; Hou M; Pan X; Li X
    Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysregulation of Hypothalamo-Pituitary-Adrenocortical Axis in Overweight Female Diabetic Subjects is Associated with Downregulation of Corticosteroid Receptors and 11β-HSD1 in the Brain.
    Li S; Liao Y; Wang L; Huang R; Yue J; Xu H; Zhou H; Lou Z; Hu Y; Liu W
    Horm Metab Res; 2016 Mar; 48(3):178-84. PubMed ID: 26212138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between neck circumference, insulin resistance and arterial stiffness in overweight and obese subjects.
    Fantin F; Comellato G; Rossi AP; Grison E; Zoico E; Mazzali G; Zamboni M
    Eur J Prev Cardiol; 2017 Sep; 24(14):1532-1540. PubMed ID: 28728486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats.
    Sakamuri VP; Ananthathmakula P; Veettil GN; Ayyalasomayajula V
    Nutr J; 2011 Jun; 10():70. PubMed ID: 21696642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population.
    Dujic T; Bego T; Mlinar B; Semiz S; Malenica M; Prnjavorac B; Ostanek B; Marc J; Causevic A
    Biochem Med (Zagreb); 2012; 22(1):76-85. PubMed ID: 22384521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.